Inbred DA (AG-B4, RT1 a) and WF (AG-B2, RT1') rats were used as donors and recipients of aortic allografts. The recipient rats were inoculated i.p. either on day 1 (early infection) or on day 60 (late infection) with iOs plaque-forming units of rat cytomegalovirus (RCMV). The control rats were left noninfected. The presence of viral infection was demonstrated by plaque assays from biopsies of the salivary glands, liver, and spleen at sacrifice. The rats received 300 gCi 13H Ithymidine by i.v. injection 3 h before sacrifice, and the grafts were removed at various time points for histology, immunohistochemistry, and autoradiography. RCMV infection significantly enhanced the generation of allograft arteriosclerosis. Infection at the time of transplantation had two important effects. First, the infection was associated with an early, prominent inflammatory episode and proliferation of inflammatory cells in the allograft adventitia. Second, the viral infection doubled the proliferation rate of smooth muscle cells and the arteriosclerotic alterations in the intima. In late infection the impact of RCMV infection on the allograft histology was nearly nonexistent. RCMV infection showed no effect in syngeneic grafts. These results suggest that early infection is more important to the generation of accelerated allograft arteriosclerosis than late infection, and that an acute alloimmune response must be associated with virus infection, to induce accelerated allograft arteriosclerosis. RCMVinfected aortic allografts, as described here, provide the first experimental model to investigate the interaction between the virus and the vascular wall of the transplant. (J. Clin. Invest. 1993. 92:549-558.)
Introduction
Cardiac transplantation is the only method currently available to return patients with end-stage heart disease to normal life. Within the past decade, short-term survival rates after heart transplantation have impressively improved, the 1-yr survival rate now being 85%. Despite the substantial improvement in early survival, the percentage of late death has not significantly reduced ( 1) . Accelerated allograft arteriosclerosis, i.e., chronic rejection, has emerged as a major factor affecting cardiac allograft sur- vival in the long run (2, 3) . It is the main cause of death after the first posttransplant year. In coronary angiography, the incidence of cardiac allograft arteriosclerosis is between 6% and 18% at 1 yr, 23% at 2 yr, and 50% at 5 yr (4, 5) , with angiographic underestimation of this disorder in some patients (6) . This phenomenon is probably due to several risk factors, such as humoral and cellular immune injury, hyperlipidemia, and infections (7) (8) (9) (10) .
Cytomegalovirus (CMV)' infection is an important cause of morbidity and mortality among heart allograft recipients ( 11) . There is also strong clinical evidence indicating the role of CMV infection in the pathogenesis of cardiac allograft arteriosclerosis (12) (13) (14) . In addition, CMV nucleic acids have been identified in the coronary arteries ofheart transplant recipients with severe accelerated allograft arteriosclerosis ( 15) . Furthermore, the possible role of herpesviruses ( 16) , in particular CMV ( [17] [18] [19] , in the pathogenesis of classical atherosclerosis has been substantiated in recent studies (20) .
As of now, no experimental animal model has been available to investigate the pathophysiology of CMV infection in the vascular wall of the transplant. Nonimmunosuppressed aortic allografts exchanged between major and minor histoincompatible rat strains develop, with time, arteriosclerotic alterations which are virtually indistinguishable from those oW served during chronic cardiac rejection in humans (21 ) . In this article we describe the first experimental animal model to study the pathophysiology of virus infection in the vascular wall of the transplant, by demonstrating that rat CMV (RCMV) infection (22, 23) significantly enhances experimental allograft arteriosclerosis.
anastomosis was performed using 9-0 continuous nylon suture. The graft was transplanted into heterotopic position below renal arteries and above bifurcation, forming a loop in the recipient abdominal cavity. Total ischemic time varied from 45 to 60 min, during which time the graft was kept in an ice bath of +40C for 15 min. The animals were anaesthetized with choral hydrate 240 mg/kg i.p., and were given 0.25 mg/kg buprenorphine s.c. (Temgesic; Reckitt & Colman, Hull, UK) for postoperative pain relief. Strain combinations DA to DA and DA to WF were used for syngeneic and allogeneic transplantations, respectively. The grafts were removed at 7 and 14 d, and 1, 3, and 6 mo after transplantation in the early infection group, and at 7 and 14 d, and 1 and 4 mo after infection in the late infection group (see below). The control rats were killed at 7 and 14 d, and 1, 2, 3, 6, and 12 mo after transplantation. Usually five successful transplantations were included in each time point. All grafts were processed for histology and autoradiography.
RCMV. RCMV Maastricht strain (22, 23) was passaged by infecting rat embryo fibroblasts, prepared from 17-d-old DA rat embryos. The cells were cultured in flasks containing modified Eagle's MEM (Flow Laboratories, Irvine, UK) supplemented with 200 mM L-glutamine (Northumbria Biologicals Ltd., Cramlington, UK), 10,000 IU/ ml penicillin/ 1,000 Mg/ml streptomycin solution (Gibco Ltd., Paisley, UK) and 2% FCS (Gibco Ltd.) according to standard viral culture techniques (24) . The stocks of virus were stored at -70'C until use.
RCMV infection in the transplant recipient. Recipient rats were inoculated i.p. with I05 plaque-forming units (PFU) of RCMV either on the 1st posttransplant day (early infection group), or on the 60th posttransplant day (late infection group). The control rats were left noninfected. The infected and noninfected rats were kept in separate colonies with otherwise similar diet and conditions.
Plaque assays for the quantitation of viral stock. Quantitation of infectious virus was done by plaque assays, using a modification ofthe method described by Wentworth and French (25), and Bruggeman et al. (22) . Confluent rat embryo fibroblast cell monolayers were infected with 200 Ml of the appropriate virus dilution and incubated for 90 min at 37°C in a 5% CO2 incubator. After the incubation, infected cells were covered with 1 ml of DME (Biological Industries, Kibbutz Beth, Haemek, Israel) with final concentration of0.25% agar (Bacto-Agar, Difco, Inc., Detroit, MI). After an incubation of 7 d the cells were fixed with 10% formaline for one night at room temperature. After the fixation, the solid base layer was removed, the cell monolayers were stained with 1% aqueous crystal violet, and the plaques were counted.
Plaque assayfor the demonstration ofRCMV infection. The biopsies from salivary glands, liver, and spleen were taken aseptically in culture medium (as above) at sacrifice, and stored at -70°C for plaque assays. In short, organs were homogenized in a tissue grinder and suspended in MEM with 2% FCS. Quantitation of infectious virus was done by plaque assays as described (22) . For this purpose 10-fold dilutions of 10% homogenates (wt/vol) were inoculated on confluent rat embryo fibroblast monolayers. After an incubation of7 d, the number of plaques was monitored microscopically after methylene blue staining.
Immunoperoxidase stainingfor RCMV antigen detection. Formaline-fixed paraffin sections, 4 Mm thick, were stained with monoclonal antibodies, directed against early and late antigens of the virus, to detect RCMV antigens in the vascular wall (26, 27 clined. In infected allografts ( Fig. 1 a) , the inflammatory episode occurred earlier with a peak at 11.6±1.5 PSU already during the 1st week (P = 0.025 at the 1st and 2nd week). After 1 mo, the intensity of inflammation in infected allografts declined to the level of noninfected allografts. The thickness of the adventitia (Fig. 1 b) relates to inflammation and edema,
and showed approximately the same time profile as did the cell nuclear counts. The media. The number of cell nuclei in the media of nontransplanted aortas was 3.1 ± 1.0 PSU (±SD). In noninfected allografts the number ofmedia nuclei remained within the normal values until 1 mo, and thereafter a rapid reduction of media nuclei occurred with a fall to 0.8±0.2 PSU at 3 mo. The reduction in the number ofcell nuclei was due to media necrosis. In infected allografts (Fig. 1 c) , the medial necrosis developed in the same course as in noninfected allografts.
The medial thickness (Fig. 1 d) (Fig. 1 e) , the number of cells increased rapidly up to 3.6±0.7 PSU at 1 mo, but remained unchanged at 3 mo (P < 0.05 at the 1st and 3rd months). At The intimal thickness of normal control aortas is nonexistent (0.1±0.1 PSU, ±SD). In noninfected allografts, the thickness ofthe intima increased steadily reaching 2.7±0.3 PSU at 3 mo, and a peak of 5.5±0.7 PSU at 6 mo. In infected allografts, intimal thickening occurred earlier (Fig. 1 f) , and the difference was significant even at 3 mo with 5.2±0.9 PSU in the infected grafts compared with noninfected controls (P < 0.05). The enhanced increase in intimal thickness continued in infected allografts, and also thereafter, though in a lesser tempo, reaching 6.7±1.6 PSU 6 mo after transplantation. There was cartilage and bone formation in two offive infected allografts at 6 mo; inasmuch as this distorts the morphological evaluation, these rats have been omitted from morphological measurements.
IP studies demonstrated that the rapid increase in the number of nuclei and thickness of intima at 1 mo in infected rats was largely due to the infiltration of LCA-positive inflammatory cells (histologically monocyte-macrophage lineage and lymphoid cells) into the intima and edema, with minor proliferation ofsmooth muscle cells. In noninfected allografts, the intimal thickening was due to smooth muscle cell proliferation, as demonstrated also earlier by staining with a-actin antibody (21 ) (Figs. 2 and 3) . After 1 mo, the cytology of intimal proliferation in infected rats resembled that of the noninfected ones.
Regression analysis. To evaluate whether the histological changes in two groups were significantly different, an additional test, the linear regression analysis ( 30, 31 ), was applied to groups of noninfected and infected allografts. This analysis demonstrated (Table I ) that the adventitial inflammation was indeed significantly stronger at day 7 after transplantation in the infected vs. noninfected allografts (P = 0.02), and that there was no difference in the intensity of media necrosis, whereas in the intima both the nuclear contents (P = 0.01 up to 3 mo) and the intimal thickness (P = 0.001 up to 3 mo) were significantly more prominent in the infected grafts. This confirms the visual interpretation and the results of Mann-Whitney U tests (indicated in Fig. 1 ) that CMV infection enhanced the early adventitial inflammation. It also enhanced intimal proliferation up to 3 mo after transplantation, whereafter the differences between the infected and noninfected groups leveled off.
INFECTION ON THE 60TH POSTTRANSPLANT DAY
The changes in the late infection group were much less impressive. The findings of this group are summarized in Fig. 4 .
The adventitia. The number of adventitial nuclei in noninfected allografts was 1 1.4±1.2 PSU at 2 mo. The infection with RCMV on the 60th posttransplant day increased only slightly the number of inflammatory cells in the adventitia up to 12.6±7.2 PSU (P = NS) in the 2nd week after infection. Thereafter, the inflammatory response declined back to control allograft level (Fig. 4 a) . The thickness of the adventitia (Fig. 4 b) followed approximately the same pace.
The media. There were 1.2±0.2 PSU of media nuclei in noninfected allografts at 2 mo. In infected allografts, media necrosis was slightly enhanced, with a fall to 0.42±0.16 PSU at the 1st week after infection (P = NS), and it remained below the level of noninfected allografts thereafter (Fig. 4 c) . The thickness of media followed the same time course (Fig. 4 d) .
The intima. At 2 mo there were 3.1±0.4 PSU of nuclei in noninfected allografts. The number of nuclei increased up to 3.5±0.50 PSU 14 d after infection (P = NS), but declined thereafter to the level of control allografts (Fig. 4 e) . The intimal thickness of noninfected allografts was 2.9±0.2 PSU at 2 mo. There was a transient increase up to 4.4±0.3 PSU in infected allografts (P = NS), whereas no difference was found after this time point (Fig. 4 f ) .
Effect of virus infection on histological changes in the syngeneic grafts
The syngeneic grafts were examined at 7 and 14 d, and 1 and 3 mo after transplantation. Changes in the three layers of the vessel wall were quantitated; normal values of control nontransplanted aorta are given above. The findings of the syngeneic grafts are summarized in Fig. 5 .
The adventitia. The number of adventitial nuclei in noninfected syngeneic grafts varied from 3.5±0.5 to 2.3±0.5 PSU at 7 d and 3 mo, respectively. In infected syngeneic grafts there was a slight inflammatory episode at 7 d, but thereafter the number of adventitial nuclei was similar to noninfected rats (Fig. 5 a) .
The media. The number of media nuclei in noninfected and infected syngeneic grafts remained within the normal values of nontransplanted aorta (3.1 ± 1.0 PSU, ±SD) during the whole observation period (Fig. 5 c) .
The intima. In noninfected syngeneic grafts, no intimal proliferation was observed. In infected syngeneic grafts, however, a slight intimal nuclear response was recorded at 1 mo, but the difference was not of statistical significance (Fig. 5 e) . In noninfected syngeneic grafts no intimal thickening was observed. In infected rats, there was only a minor increase in intimal thickness at 1 mo (Fig. 5 f ) . Taken together, viral infection on syngeneic transplants had no impact.
Effect of virus infection on the histological changes in the nontransplanted descending thoracic aorta
No morphological alterations were observed in the native thoracal aorta of the infected rats. .. .. in the adventitia lasted for 3 mo, and declined thereafter. In infected allografts there was a more rapid and intensive peak of white cell proliferation at the 1st posttransplant week 227±21 (P < 0.05). Thereafter the proliferative response declined gradually, returning to the level of noninfected allografts, and declining even below that after 1 mo (P < 0.025 at 1 and 3 mo, P < 0.05 at 6 mo) (Fig. 6 a) .
Media cell proliferation. There was also an increase in the number of ['H]TdR incorporating cells in the media of noninfected allografts lasting for 1-3 mo. In infected allografts, the increase was more prominent at the 1st and 2nd weeks (P < 0.05 at 1 wk, P < 0.025 at 2 wk), but declined thereafter (Fig. 6 b) .
Intimal cell proliferation. Proliferating cells in the intima of noninfected allografts were first observed after 2 wk. Thereafter, the proliferative response in the intima continued at least for 6 mo, i.e., to the end of the observation time. In infected allografts, the intimal cell proliferation was more intensive throughout the observation time (P < 0.025 at 1 wk; thereafter NS) (Fig. 6 c) .
Cell proliferation in late infection group and syngeneic grafts. Cell proliferation in the late infection group and syngeneic grafts did not differ from that of noninfected transplants, neither did the histological response to viral infection (Figs. 7  and 8 ).
Discussion
Strong clinical evidence has been recently provided that CMV infection enhances cardiac allograft arteriosclerosis in human heart allografts (12) (13) (14) . In addition, an association of CMV infection in cardiac transplant recipients with more frequent allograft rejections and death is suggested in one of these studies (12) . Furthermore, a link between viral infections, especially herpesviruses, and classical atherosclerosis is substantiated by the observations of Fabricant et al. ( 16) , who showed that Marek's disease herpesvirus caused atherosclerotic lesions in chicken which closely resembled those observed in classical atherosclerosis in human arteries.
In this report we provide, for the first time, experimental evidence that CMV infection accelerates allograft arteriosclerosis. RCMV infection at the time of transplantation has two important effects on the generation ofaccelerated arteriosclerosis in aortic allografts. First, the infection is associated with an early prominent inflammatory episode and proliferation of inflammatory cells in the allograft adventitia. Second, the viral infection doubled the proliferation of smooth muscle cells and the arteriosclerotic alterations in the intima. We consider the accelerated intimal changes, which have been observed only in virus-infected allografts, to be due to the early prominent inflammation in the arterial wall. The specificity of the early replicating lymphoid cell populations in the allograft infiltrate have not yet been defined. If the timepoint of infection is postponed by 2 mo, the impact of RCMV infection on the allograft histological changes is small. This is also the case if syngeneic grafts are infected with RCMV at the time of transplantation. Thus, an acute alloimmune response must be associated with virus infection, to induce accelerated allograft arteriosclerosis. Our studies in CMV infected human heart allografts have demonstrated that a similar inflammatory response, subendothelial lymphocytosis, in vessel walls with alterations of small intramyocardial arterioles leading to narrowing of the vascular lumen of the graft were related to CMV infection (33) .
What would then be the plausible mechanisms whereby CMV infection enhances allograft arteriosclerosis? CMV is capable of infecting components of the vascular wall, in particular, endothelial cells (34) (35) (36) and smooth muscle cells (37) . Like all other herpesviruses, CMV is able to turn into the latent state after acute infection. In latent CMV infection of smooth muscle cells ( 19) , detected by tracing viral genes and antigens ( 17, 18) , the virus may transform the smooth muscle cells by incorporating into the cell genome, and induce local proliferation and changes in cellular metabolism of these cells, e.g., production of different growth factors, without destroying them (38) (39) (40) . These possibilities will be considered in an separate communication.
Early interaction with granulocytes (46), leading to cell damage through enzyme release and oxygen radicals. Furthermore, human CMV infection up-regulates IL-1,8 gene expression leading to increased production of IL-1 by monocyte-macrophage cell lineage, and to enhancement of inflammatory responses (47) .
The immediate early gene of human CMV is able to code for a protein that has sequence homology and immunologic cross-reactivity with HLA-DR 13 chain, thus possibly enhancing alloimmune responses to donor antigens (48) . CMV also Proliferating response of smooth muscle cells in RCMV infected and noninfected allografts seems to be a self-limiting process. As clearly seen in autoradiograms, in noninfected allografts the proliferation of smooth muscle cells in the intima declines close to zero level at 10-12 mo after transplantation, whereas in RCMV-infected allografts, where the response takes place earlier and is more intense, the proliferation stops already at 5-6 mo after transplantation. After this time point, the histological lesion also stops progressing, but plateaus off. Hayflick (51) To conclude, our studies demonstrate that RCMV infection enhances allograft arteriosclerosis in rat aortic allografts, with the prerequisite that an acute alloimmune response and acute virus infection coincide. When applied to the clinical situation, the results emphasize that CMV-negative recipient receiving a CMV-positive graft is in particularly great danger of developing enhanced graft arteriosclerosis. Our experiments
have not yet provided any conclusive answer as to which are the molecular mechanisms of viral infection in the vascular wall. Tracking of viral antigens and viral genome in the graft and descending thoracic aorta of the recipient is in progress. This experimental animal model will make it possible, for the first time, to investigate the pathophysiology of viral infection in the vascular wall of transplant recipients, and enables us to develop logistics for prophylaxis and treatment of CMV-enhanced allograft arteriosclerosis with antiviral regimens. encodes a glycoprotein homologous with the heavy chain of MHC class-I antigens that has the ability to bind the light chain of MHC class-I molecule, i.e., to the 32-microglobulin (49) . These inflammatory and immunologic phenomena in response to injury (50) induced by viral infection may lead to endothelial cell monolayer damage, and to the exposure of smooth muscle cells to cytokines and growth factors and to the virus itself. These possibilities will be answered in future studies. 
